The evolution of acute myeloid leukaemia by in situ transformation of haematopoietic stem cells [ 2016 - ]

Research Grant

Researchers: A/Pr Steven Lane (Principal investigator)

Brief description Acute myeloid leukaemia (AML) is a devastating form of blood cancer that can affect people of any age. The survival of patients with AML is poor and this is because the disease usually comes back after chemotherapy (this is called relapse). Fewer than half of all patients with AML can be cured. We have recently developed a new, and improved, model of AML in the lab, which we will use to test an exciting new treatment for patients with AML.

Funding Amount $646,966.00

Funding Scheme Project Grants

Notes Standard Project Grant